217 related articles for article (PubMed ID: 36611191)
1. Amide Proton Transfer-weighted MRI combined with serum prostate-specific antigen levels for differentiating malignant prostate lesions from benign prostate lesions: a retrospective cohort study.
Yang L; Wang L; Tan Y; Dan H; Xian P; Zhang Y; Tan Y; Lin M; Zhang J
Cancer Imaging; 2023 Jan; 23(1):3. PubMed ID: 36611191
[TBL] [Abstract][Full Text] [Related]
2. Amide proton transfer-weighted magnetic resonance imaging for the differentiation of parotid gland tumors.
Wang Y; Wang L; Huang H; Ma J; Lin L; Liu L; Song Q; Liu A
Front Oncol; 2023; 13():1223598. PubMed ID: 37664057
[TBL] [Abstract][Full Text] [Related]
3. Synthetic MRI and amide proton transfer-weighted MRI for differentiating between benign and malignant sinonasal lesions.
Xiang Y; Zhang Q; Chen X; Sun H; Li X; Wei X; Zhong J; Gao B; Huang W; Liang W; Sun H; Yang Q; Ren X
Eur Radiol; 2024 Mar; ():. PubMed ID: 38491129
[TBL] [Abstract][Full Text] [Related]
4. Quantitative apparent diffusion coefficient metrics for MRI-only suspicious breast lesions: any added clinical value?
Li X; Wang H; Gao J; Jiang L; Chen M
Quant Imaging Med Surg; 2023 Oct; 13(10):7092-7104. PubMed ID: 37869329
[TBL] [Abstract][Full Text] [Related]
5. Combining Magnetic Resonance Diffusion-Weighted Imaging with Prostate-Specific Antigen to Differentiate Between Malignant and Benign Prostate Lesions.
Han L; He G; Mei Y; Yu Q; Zhao M; Luo F; Cheng G; Liang W
Med Sci Monit; 2022 Apr; 28():e935307. PubMed ID: 35459760
[TBL] [Abstract][Full Text] [Related]
6. Adding quantitative T1rho-weighted imaging to conventional MRI improves specificity and sensitivity for differentiating malignant from benign breast lesions.
Wang L; Wang X; Jiang F; Cao Y; Liu S; Chen H; Yang J; Zhang X; Yu T; Xu H; Lin M; Wu Y; Zhang J
Magn Reson Imaging; 2024 May; 108():98-103. PubMed ID: 38331054
[TBL] [Abstract][Full Text] [Related]
7. Amide proton transfer-weighted MRI for renal tumors: Comparison with diffusion-weighted imaging.
Xu Y; Wan Q; Ren X; Jiang Y; Wang F; Yao J; Wu P; Shen A; Wang P
Magn Reson Imaging; 2024 Feb; 106():104-109. PubMed ID: 38135260
[TBL] [Abstract][Full Text] [Related]
8. [The value of DISCO and MUSE-DWI combined with prostate specific antigen density in the diagnosis and risk stratification of prostate cancer].
Chen ZQ; Zhang D; Wang Z; Song N; Ma AL; Zhang SR; Cai L
Zhonghua Yi Xue Za Zhi; 2023 May; 103(19):1461-1468. PubMed ID: 37198108
[No Abstract] [Full Text] [Related]
9. Significant Diagnostic Value of Free-Serum PSA (FPSA)/Prostate-Specific Antigen Density (PSAD) and (F/T)/PSAD for Prostate Cancer of the Chinese Population in a Single Institution.
Nan LB; Yin XT; Gao JP
Med Sci Monit; 2019 Nov; 25():8345-8351. PubMed ID: 31691648
[TBL] [Abstract][Full Text] [Related]
10. Comparative Analysis of Amide Proton Transfer MRI and Diffusion-Weighted Imaging in Assessing p53 and Ki-67 Expression of Rectal Adenocarcinoma.
Li L; Chen W; Yan Z; Feng J; Hu S; Liu B; Liu X
J Magn Reson Imaging; 2020 Nov; 52(5):1487-1496. PubMed ID: 32524685
[TBL] [Abstract][Full Text] [Related]
11. [Preliminary applicability evaluation of Prostate Imaging Reporting and Data System version 2 diagnostic score in 3.0T multi-parameters magnetic resonance imaging combined with prostate specific antigen density for prostate cancer].
Zuo MZ; Zhao WL; Wei CG; Zhang CY; Wen R; Gu YF; Li MJ; Zhang YY; Wu JF; Li X; Shen JK
Zhonghua Yi Xue Za Zhi; 2017 Dec; 97(47):3693-3698. PubMed ID: 29325321
[No Abstract] [Full Text] [Related]
12. Breast-lesion assessment using amide proton transfer-weighted imaging and dynamic contrast-enhanced MR imaging.
Zhuang L; Lian C; Wang Z; Zhang X; Wu Z; Huang R
Radiol Oncol; 2023 Dec; 57(4):446-454. PubMed ID: 38038421
[TBL] [Abstract][Full Text] [Related]
13. Retrospective analysis of the utility of multiparametric MRI for differentiating between benign and malignant breast lesions in women in China.
Fan WX; Chen XF; Cheng FY; Cheng YB; Xu T; Zhu WB; Zhu XL; Li GJ; Li S
Medicine (Baltimore); 2018 Jan; 97(4):e9666. PubMed ID: 29369183
[TBL] [Abstract][Full Text] [Related]
14. The Value of Amide Proton Transfer MRI in the Diagnosis of Malignant and Benign Urinary Bladder Lesions: Comparison With Diffusion-Weighted Imaging.
Li JL; Xu Y; Xiang YS; Wu P; Shen AJ; Wang PJ; Wang F
J Magn Reson Imaging; 2024 Jan; ():. PubMed ID: 38174777
[TBL] [Abstract][Full Text] [Related]
15. Grading diffuse gliomas without intense contrast enhancement by amide proton transfer MR imaging: comparisons with diffusion- and perfusion-weighted imaging.
Togao O; Hiwatashi A; Yamashita K; Kikuchi K; Keupp J; Yoshimoto K; Kuga D; Yoneyama M; Suzuki SO; Iwaki T; Takahashi M; Iihara K; Honda H
Eur Radiol; 2017 Feb; 27(2):578-588. PubMed ID: 27003139
[TBL] [Abstract][Full Text] [Related]
16. Grading of Glioma: combined diagnostic value of amide proton transfer weighted, arterial spin labeling and diffusion weighted magnetic resonance imaging.
Kang XW; Xi YB; Liu TT; Wang N; Zhu YQ; Wang XR; Guo F
BMC Med Imaging; 2020 May; 20(1):50. PubMed ID: 32408867
[TBL] [Abstract][Full Text] [Related]
17. Multiparametric MRI model with dynamic contrast-enhanced and diffusion-weighted imaging enables breast cancer diagnosis with high accuracy.
Zhang M; Horvat JV; Bernard-Davila B; Marino MA; Leithner D; Ochoa-Albiztegui RE; Helbich TH; Morris EA; Thakur S; Pinker K
J Magn Reson Imaging; 2019 Mar; 49(3):864-874. PubMed ID: 30375702
[TBL] [Abstract][Full Text] [Related]
18. Differentiation of Benign From Malignant Sinonasal Masses Using Diffusion Weighted Imaging and Dynamic Contrast Enhanced Magnetic Resonance Imaging.
Daga R; Kumar J; Pradhan G; Meher R; Malhotra V; Khurana N
Am J Rhinol Allergy; 2022 Mar; 36(2):207-215. PubMed ID: 34486401
[TBL] [Abstract][Full Text] [Related]
19. Synthetic MRI in breast cancer: differentiating benign from malignant lesions and predicting immunohistochemical expression status.
Li X; Fan Z; Jiang H; Niu J; Bian W; Wang C; Wang Y; Zhang R; Zhang H
Sci Rep; 2023 Oct; 13(1):17978. PubMed ID: 37864025
[TBL] [Abstract][Full Text] [Related]
20. [The value of synthetic MRI in differential diagnosis of benign and malignant breast lesions].
Che SN; Li J; Xue M; Song Y; Zhao LY; Guo N; Tian Y; Xie LZ; Zhao XM; Zhou CW
Zhonghua Zhong Liu Za Zhi; 2021 Aug; 43(8):872-877. PubMed ID: 34407594
[No Abstract] [Full Text] [Related]
[Next] [New Search]
